Data driven value Leverage Prognos Health’s extensive real-world data platform and de-identified lab data to offer researchers and life sciences brands precise audience segmentation and improved target accuracy for studies, trials, and marketing initiatives.

Healthcare partnerships Capitalize on ongoing and recent collaborations with Massive Bio, Doceree, Throtle, and BioReference Laboratories to position joint solutions that blend RWD with clinical expertise, physician engagement channels, and identity resolution for broader market reach.

Oncology & precision Target growth in oncology solutions by highlighting Prognos Oncology and lab-based precision marketing capabilities to pharma sponsors pursuing real-world evidence, trial enrollment optimization, and tailored therapeutic strategies.

Platform expansion Position the platform’s scalability across Azure, Snowflake, and open AI capabilities to support large-scale data harmonization, advanced analytics, and automated insight delivery for drug development and payer decision support.

Financial health With revenue in the mid-range and a substantial growth potential, present opportunities for strategic partnerships, co-marketing, and data licensing deals that can accelerate product adoption among mid-to-large pharma clients seeking RWD solutions.